Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.53USD
20 Apr 2018
Change (% chg)

$0.01 (+1.28%)
Prev Close
$0.52
Open
$0.53
Day's High
$0.54
Day's Low
$0.53
Volume
4,805
Avg. Vol
53,220
52-wk High
$2.91
52-wk Low
$0.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Feb '18 0.33 -0.091
FY 2017 Nov '17 1.08 -0.076
Aug '17 1.19 -0.083
May '17 2.00 -0.059
Feb '17 1.24 -0.066
FY 2016 Nov '16 0.57 -0.134
Aug '16 0.55 -0.074
May '16 0.56 -0.081
Feb '16 0.57 -0.087
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending May-18 2 1.18 1.61 0.76 10.32
Quarter Ending Aug-18 2 1.83 1.89 1.76 10.56
Year Ending Nov-18 2 6.06 6.92 5.20 39.34
Year Ending Nov-19 1 11.52 11.52 11.52 75.12
Earnings (per share)
Quarter Ending May-18 1 -0.06 -0.06 -0.06 0.16
Quarter Ending Aug-18 1 -0.04 -0.04 -0.04 0.16
Year Ending Nov-18 1 -0.22 -0.22 -0.22 0.52
Year Ending Nov-19 1 -0.08 -0.08 -0.08 1.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.01 33.60
P/E High - Last 5 Yrs. -- 40.51 45.95
P/E Low - Last 5 Yrs. -- 24.14 24.93
Beta 1.25 0.82 0.80
Price to Sales (TTM) 5.08 4.52 7.07
Price to Book (MRQ) -- 4.11 5.13
Price to Tangible Book (MRQ) -- 4.99 6.73
Price to Cash Flow (TTM) -- 22.60 25.52
% Owned Institutions 0.49 1.16 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.51
Dividend Yield - 5 Year Avg -- 0.72 0.75
Dividend 5 Year Growth Rate -- 2.72 3.93
Payout Ratio(TTM) -- 20.12 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -72.92 6.90 9.02
Sales (TTM) vs TTM 1 Yr. Ago 57.90 9.71 10.83
Sales - 5 Yr. Growth Rate 119.88 7.67 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -36.59 19.14 22.25
EPS (TTM) vs TTM 1 Yr. Ago 13.02 -- --
EPS - 5 Yr. Growth Rate -- 8.96 10.26
Capital Spending - 5 Yr. Growth Rate 11.97 9.66 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.25 2.53 2.53
Current Ratio (MRQ) 0.29 3.62 3.62
LT Debt to Equity (MRQ) -- 8.61 11.31
Total Debt to Equity (MRQ) -- 10.92 13.97
Interest Coverage (TTM) -23.50 35.68 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 77.44 54.62 54.01
Gross Margin - 5 Yr. Avg. -- 52.07 52.12
EBITD Margin (TTM) -193.99 -- --
EBITD - 5 Yr. Avg -151.38 18.40 15.89
Operating Margin (TTM) -206.54 12.92 4.33
Operating Margin - 5 Yr. Avg. -161.21 14.20 11.25
Pre-Tax Margin (TTM) -217.57 13.17 4.97
Pre-Tax Margin - 5 Yr. Avg. -188.73 14.56 11.56
Net Profit Margin (TTM) -217.57 9.57 1.58
Net Profit Margin - 5 Yr. Avg. -188.73 10.88 7.89
Effective Tax Rate (TTM) -- 22.52 31.30
Effective Tax Rate - 5 Yr. Avg. -- 23.67 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 922,802,967 816,988,634
Net Income/Employee (TTM) -- 108,527,563 96,050,323
Receivable Turnover (TTM) 7.74 5.62 5.56
Inventory Turnover (TTM) 2.29 2.56 3.45
Asset Turnover (TTM) 0.69 0.92 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -150.03 10.96 10.54
Return on Assets - 5 Yr. Avg. -137.51 12.17 11.56
Return on Investment (TTM) -662.80 13.60 13.19
Return on Investment - 5 Yr. Avg. -429.25 15.72 14.97
Return on Equity (TTM) -- 15.26 15.00
Return on Equity - 5 Yr. Avg. -- 16.89 16.25
  1 Year 3 Year 5 Year
Sales % 144.97 -14.38 119.88
EPS (TTM) % 24.83 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellipharmaceutics International Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.